A citation-based method for searching scientific literature

Mark E Robson, Angela R Bradbury, Banu Arun, Susan M Domchek, James M Ford, Heather L Hampel, Stephen M Lipkin, Sapna Syngal, Dana S Wollins, Noralane M Lindor. J Clin Oncol 2015
Times Cited: 283

Allison W Kurian, Emily E Hare, Meredith A Mills, Kerry E Kingham, Lisa McPherson, Alice S Whittemore, Valerie McGuire, Uri Ladabaum, Yuya Kobayashi, Stephen E Lincoln, Michele Cargill, James M Ford. J Clin Oncol 2014
Times Cited: 294

List of shared articles

Times cited

Mainstream consent programs for genetic counseling in cancer patients: A systematic review.
Tahlia Scheinberg, Alison Young, Henry Woo, Annabel Goodwin, Kate L Mahon, Lisa G Horvath. Asia Pac J Clin Oncol 2021

Economic impact of multigene panel testing for hereditary breast and ovarian cancer.
Stacey Dacosta Byfield, Helen Wei, Mary DuCharme, Johnathan M Lancaster. J Comp Eff Res 2021

Current Approaches to Germline Cancer Genetic Testing.
Elena M Stoffel, John M Carethers. Annu Rev Med 2020

Genetic Predisposition to Breast and Ovarian Cancers: How Many and Which Genes to Test?
Davide Angeli, Samanta Salvi, Gianluca Tedaldi. Int J Mol Sci 2020

The American Association of Endocrine Surgeons Guidelines for the Definitive Surgical Management of Thyroid Disease in Adults.
Kepal N Patel, Linwah Yip, Carrie C Lubitz, Elizabeth G Grubbs, Barbra S Miller, Wen Shen, Peter Angelos, Herbert Chen, Gerard M Doherty, Thomas J Fahey,[...]. Ann Surg 2020

Development and Validation of a 34-Gene Inherited Cancer Predisposition Panel Using Next-Generation Sequencing.
Sun Hee Rosenthal, Weimin Sun, Ke Zhang, Yan Liu, Quoclinh Nguyen, Anna Gerasimova, Camille Nery, Linda Cheng, Carolyn Castonguay, Elaine Hiller,[...]. Biomed Res Int 2020

Development and validation of next generation sequencing based 35-gene hereditary cancer panel.
Wing Chan, Mianne Lee, Zhen Xuan Yeo, Dingge Ying, Keith A Grimaldi, Craig Pickering, Michael M S Yang, Senthil K Sundaram, Lawrence C H Tzang. Hered Cancer Clin Pract 2020

Clinical validity assessment of genes frequently tested on hereditary breast and ovarian cancer susceptibility sequencing panels.
Kristy Lee, Bryce A Seifert, Hermela Shimelis, Rajarshi Ghosh, Stephanie B Crowley, Natalie J Carter, Kurston Doonanco, A Katherine Foreman, Deborah I Ritter, Sharisse Jimenez,[...]. Genet Med 2019